Ethambutol/isoniazid is a medication used to treat tuberculosis. It is a fixed dose combination of ethambutol and isoniazid. It is used along with other antituberculosis medication. It is taken by mouth.
Side effects are those of the underlying medications. More common side effects include poor coordination, numbness, and liver problems. Liver problems may be severe and are more likely in people over the age of 50. Use is not recommended in children. It is unclear if use in pregnancy is safe for the baby.
It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is about 1.47 to 1.99 USD a month. The combination product is not available in Canada or the United States.
- WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 140. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- "Ethambutol and Isoniazid Drug Information, Professional". www.drugs.com. November 1998. Archived from the original on 21 December 2016. Retrieved 18 December 2016.
- "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- "Ethambutol + Isoniazid". International Drug Price Indicator Guide. Retrieved 8 December 2016.